Refine by
Biopharmaceutical Research Articles & Analysis
38 news found
Watertown, MA - June 29, 2025 - Biopharma PEG, a leading innovator in high-quality polyethylene glycol (PEG) derivatives, today announced it has successfully obtained Drug Master File (DMF) approval from the U.S. Food and Drug Administration (FDA) for its self-developed HZ-PEG-HZ (1K) product. The assigned DMF number is 041864. This significant achievement underscores Biopharma PEG's robust ...
"Our LncRNA Sequencing service empowers researchers to delve into this untapped regulatory landscape, paving the way for groundbreaking discoveries in diverse fields, from developmental biology to disease pathogenesis." ...
As a PDA member, Board Member, and PDA Chair, Jette’s dedication to PDA’s mission of advancing pharmaceutical/biopharmaceutical manufacturing science and regulation so members can better serve patients benefited not only PDA members but the entire industry. Created through the PDA Foundation for Pharmaceutical Education, Training, and Research, the ...
Biopharma PEG, a leading name in the pharmaceutical industry, is proud to announce a groundbreaking advancement in the field of Antibody-Drug Conjugate (ADC) development. The company now offers monodispersed Polyethylene Glycols (PEGs) on a scale ranging from grams to kilograms, and even on a ton scale. Notable PEGs include mPEG36-NH2, NH2-PEG24-COOH, OH-PEG9-OH, mPEG8-SPA, and more.ADCs ...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has launched a new line of Locust Bean Gum with advanced technical platforms to help scientists advance biopharmaceutical research. Over the past few decades, researchers have been working on developing delivery systems that can reduce side ...
Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software, announced today a new partnership to advance glycoproteomics and biotherapeutics tools and research Macquarie University’s Analytical Glycoimmunology Group and Protein Metrics Inc. today have launched a strategic partnership scheme to further advance ...
Despite this apparent success, there are issues with biopharmaceutical antibody research and development – not least the cost of goods. ...
Mammoth Biosciences, a biotech company harnessing next-generation CRISPR technology to detect and cure disease, has been chosen by Endpoints News Editor John Carroll as one of the most promising biotech startups for this year’s Endpoints 11 annual special report. Comprising a team of scientist-founders, experienced biopharma veterans, and talented researchers, Mammoth is developing a ...
Cannabinoids and Radiation – Recent research from Columbia University shows that cannabinoids, a class of chemicals best known because of their presence in cannabis, may be able to enhance the effectiveness of radiotherapy. ...
Health Canada approved the amendment of the phase I study to assess the effect of low and moderate doses of inhaled CBD in healthy cannabinoid users. The collaboration with the CRCHUM will allow Tetra to obtain phase I clinical data on inhaled CBD. OTTAWA, ON, March 8, 2022 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in ...
CD BioGlyco, a biotechnology company that provides a full range of glycobiology-related products, analysis, custom synthesis, and design to help advance glycobiology research, recently released a glyco-engineered mammalian cell expression system to help scientists with their research. ...
In recent years, there has been a global upsurge in the research and development of antibody-drug conjugates (ADCs). ADCs are novel therapeutic biotechnology drugs that are conjugated with monoclonal antibodies and small-molecule drugs with strong cytotoxicity through biologically active linkers. ...
Protein Metrics' Byos Platform enables researchers to move from raw data files to report in just minutes, with the click of a mouse. ...
The company is headquartered in Chadds Ford, Pennsylvania within the Philadelphia biopharmaceutical and medical innovation corridor. About Lipidomics Consulting Ltd. ...
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, has entered into an assay development agreement with the global, science-led biopharmaceutical company AstraZeneca (LSE/STO/Nasdaq: AZN). SAGA Diagnostics will in the course of this agreement develop unique SAGAsafe® dPCR ...
We hired our commercial team and are now ready to bring HRIM to our biopharma and research scientist customers more broadly.” In 2018, MOBILion announced its partnership with Agilent Technologies to integrate their first HRIM system with Agilent’s 6500 line of Q-TOF Mass Spectrometers to provide a tool for pharmaceutical companies to develop safer and more effective ...
MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research and development of novel antibiotics for the treatment of serious bacterial infections, today announced the successful completion of a growth financing round raised via a private placement to European strategic investors. ...
With years of experience in offering professional and high-quality products for academic use and pharmaceutical industries, Creative Proteomics announces diversified PEGylated protein analysis technologies, which can solve important research and development problems in the quality control and pharmacokinetic research of biotechnology drugs. ...
Overlaying WQP’s novel AI technology platform, Quanto, with the exhaustive repository of data from the CAS REGISTRY, the groundbreaking initiative was led by WQP scientific advisor and former Pfizer Senior Vice President in research and development, Kelvin Cooper, Ph.D. The goal of this project was to create a virtual screening tool model that can be replicated by outside ...
MOBILion’s HRIM product addresses deficiencies in current biopharmaceutical characterization workflows that rely on Liquid Chromatography Mass Spectrometry (LC- MS). ...